AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BB Biotech AG

Director's Dealing Feb 21, 2024

833_dirs_2024-02-21_28a220b7-a090-4aa6-b7bf-9e7af0a55991.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 21 February 2024 17:40

BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

21.02.2024 / 17:40 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title: Prof. Dr.
First name: Mads Krogsgaard
Last name(s): Thomsen

2. Reason for the notification

a) Position / status

Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

BB BIOTECH AG

b) LEI

391200MBZQNPFHIVKO34

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: CH0038389992

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s) Volume(s)
49.2826 CHF 874,766.15 CHF

d) Aggregated information

Price Aggregated volume
49.2826 CHF 874,766.15 CHF

e) Date of the transaction

2024-02-16; UTC+1

f) Place of the transaction

Name: SIX Swiss Exchange
MIC: XSWX

21.02.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com


Language: English
Company: BB BIOTECH AG
Schwertstrasse 6
8200 Schaffhausen
Switzerland
Internet: www.bbbiotech.ch
End of News EQS News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.